Learn more about the technology.
During surgery, an incision is cut through the skin and tissue of the body and then closed using products such as surgical stitches, staples or a combination of these methods. However, any surgery presents risks that can complicate recovery.
Taking care of your incision is a key step that may impact both your recovery time and your quality of life.
Prevena Therapy is a portable, disposable system, that uses negative pressure (like a vacuum) to help protect and manage your incision. It is the first device indicated by FDA to help reduce superficial surgical site infections in patients at high-risk for post-operative complications in Class I and Class II wounds.*
Dr. John Cooper discusses using Prevena Therapy on high-risk orthopedic patients.
Prevena Therapy is a prescription-only device. As with most medical devices, there are risks involved which is why you should always consult with your doctor about whether the therapy is right for you.
Download the Patient Brochure (PDF, 771 KB) to help aid in the conversation
†3M™ Prevena™ Therapy 125 Patient Guide
3M™ Prevena™ Therapy Plus 125 Patient Guide
1. Zimlichman E, Henderson D, Tamir, et al. Health care-associated Infections a meta-analysis of costs and financial impact on the U.S. health care system. JAMA Intern ed.2013;173(22):20-46.
2. Magill SS, Edwards JR, Bamberg W, et al. Multistate point-prevalence survey of health care-associated Infections. N Engl JMed. 2014;370:1198-208.
3. Shepard J, Ward W, Milstone A, et al. Financial impact of surgical site infections on hospitals. The hospital management perspective. JAMA Surg. 2013;148(10):907-914. doi:10.1001/jamasurg.2013.2246
3M™ Prevena™ 125 and 3M™ Prevena™ Plus 125 Therapy Units manage the environment of closed surgical incisions and remove fluid away from the surgical incision via the application of -125mmHg continuous negative pressure. When used with legally marketed compatible dressings, Prevena 125 and Prevena Plus 125 Therapy Units are intended to aid in reducing the incidence of seroma and, in patients at risk for post-operative infections, aid in reducing the incidence of superficial surgical site infection in Class I and II wounds.
The effectiveness of Prevena Therapy in reducing the incidence of SSIs and seroma in all surgical procedures and populations has not been demonstrated. See full indications for use and limitations at mykci.com.
NOTE: Applicable therapy units include Prevena 125 Therapy Unit and Prevena Plus 125 Therapy Unit 7 Day.
The indication statement does not apply to the Prevena Plus 125 Therapy Unit (14-day) that comes with the 3M™ Prevena Restor™ System Kits (see Prevena Restor™ System indications for use).
The 3M™ Prevena Restor™ Incision Management System is intended to manage the environment of surgical incisions that continue to drain following sutured or stapled closure by maintaining a closed environment and removing exudate via the application of negative pressure wound therapy.
NOTE: Specific indications, limitations, contraindications, warnings, precautions and safety information exist for these products and therapies. Please consult a clinician and product instructions for use prior to application. Rx only.